NCT07132567View on ClinicalTrials.gov

Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

RecruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

May 2, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

November 30, 2028

Conditions
Mycosis FungoidesSezary Syndrome
Interventions
DRUG

Poteligeo 20mg

Poteligeo 20mg

Trial Locations (6)

49267

RECRUITING

Kosin University Gospel Hospital, Busan

Unknown

TERMINATED

Chung-Ang University Hospital, Seoul

RECRUITING

Ewha Womans University Mokdong Hospital, Seoul

RECRUITING

Samsung Medical Center, Seoul

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY